<DOC>
	<DOCNO>NCT01392755</DOCNO>
	<brief_summary>This randomize , open-label study evaluate effect food , effect omeprazole ranitidine danoprevir co-administered ritonavir . Volunteers assign one two treatment group . Volunteers group receive oral dos danoprevir ritonavir . In addition , volunteer group 2 receive oral dos omeprazole ranitidine . The anticipated time study approximately 6 week .</brief_summary>
	<brief_title>A Study Evaluate The Effects Two Different Meal Types , Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<criteria>Adult healthy volunteer , age 18 45 year , inclusive Weight &gt; /= 50.0 kg Body Mass Index ( BMI ) 18.0 32.0 kg/m2 , inclusive Presence active chronic disease Abnormal blood pressure Abnormal rest heart rate Abnormal ECG value History clinically significant cardiovascular cerebrovascular disease Current smokers subject discontinue smoke &lt; 6 month prior first dose study drug Positive hepatitis B , hepatitis C HIV Positive test drug abuse alcohol Positive result H. pylorus Regular use antacid , H2 blocker , proton pump inhibitor , investigational drug within 30 day first dose study medication History clinically significant gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>